These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4031788)

  • 21. Leishmania major: identification of stage-specific antigens and antigens shared by promastigotes and amastigotes.
    Handman E; Jarvis HM; Mitchell GF
    Parasite Immunol; 1984 May; 6(3):223-33. PubMed ID: 6739119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of cross-reactive promastigote cell surface antigens of some leishmanial stocks by 125I labeling and immunoprecipitation.
    Gardiner PR; Jaffe CL; Dwyer DM
    Infect Immun; 1984 Feb; 43(2):637-43. PubMed ID: 6363295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Leishmania antigen on the surface membrane of infected human macrophages in vitro.
    Berman JD; Dwyer DM
    Clin Exp Immunol; 1981 May; 44(2):342-8. PubMed ID: 7030533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inoculation of BALB/c mice against Leishmania major infection with Leishmania-derived antigens isolated by gel filtration.
    Ogunkolade BW; Monjour L; Vouldoukis I; Rhodes-Feuillette A; Frommel D
    J Chromatogr; 1988 May; 440():459-65. PubMed ID: 3403672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of three ELISA tests using promastigote homogenates of Leishmania braziliensis, L. amazonensis and L. guyanensis in the diagnosis of tegumentary leishmaniasis].
    Gil JF; Hoyos CL; Cimino RO; Krolewiecki AJ; López Quiroga I; Cajal SP; Juárez M; García Bustos MF; Mora MC; Marco JD; Nasser JR
    Medicina (B Aires); 2011; 71(5):420-8. PubMed ID: 22057166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.
    Jaffe CL; Rachamim N; Sarfstein R
    J Immunol; 1990 Jan; 144(2):699-706. PubMed ID: 2295807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of lipophosphoglycan-associated epitopes in different Leishmania species and in African trypanosomes.
    Tolson DL; Schnur LF; Jardim A; Pearson TW
    Parasitol Res; 1994; 80(6):537-42. PubMed ID: 7528916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that the major surface proteins of three Leishmania species are structurally related.
    Etges RJ; Bouvier J; Hoffman R; Bordier C
    Mol Biochem Parasitol; 1985 Feb; 14(2):141-9. PubMed ID: 3990704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis.
    Jaffe CL; Bennett E; Grimaldi G; McMahon-Pratt D
    J Immunol; 1984 Jul; 133(1):440-7. PubMed ID: 6373932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.
    Sacks DL; Hieny S; Sher A
    J Immunol; 1985 Jul; 135(1):564-9. PubMed ID: 2582050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of cellular immune response to chemically defined glycoconjugates from Leishmania mexicana subsp. amazonensis.
    Rodrigues MM; Xavier MT; Previato LM; Barcinski MA
    Infect Immun; 1986 Jan; 51(1):80-6. PubMed ID: 2416692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PSA-2 glycoprotein complex of Leishmania major is a glycosylphosphatidylinositol-linked promastigote surface antigen.
    Murray PJ; Spithill TW; Handman E
    J Immunol; 1989 Dec; 143(12):4221-6. PubMed ID: 2592773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies to Leishmania tropica major: specificities and antigen location.
    de Ibarra AA; Howard JG; Snary D
    Parasitology; 1982 Dec; 85 (Pt 3)():523-31. PubMed ID: 6184664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
    Pan AA; McMahon-Pratt D
    J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serodiagnosis of leishmaniasis.
    Kar K
    Crit Rev Microbiol; 1995; 21(2):123-52. PubMed ID: 7639932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cloning of the major surface antigen of leishmania.
    Button LL; McMaster WR
    J Exp Med; 1988 Feb; 167(2):724-9. PubMed ID: 3346625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leishmania tropica: differences in the antigenicity of promastigotes and amastigotes.
    Sadick MD; Raff HV
    Cell Immunol; 1985 Apr; 91(2):404-14. PubMed ID: 3873282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the antigenic profile of Leishmania parasites following shifts in temperature.
    Fehniger TE; Mengistu G; Gessesse A; Gabre-Mariam H; Akuffo H
    Acta Trop; 1990 May; 47(4):227-36. PubMed ID: 1694627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parasite antigens, their role in protection, diagnosis and escape: the leishmaniases.
    Alexander J; Russell DG
    Curr Top Microbiol Immunol; 1985; 120():43-67. PubMed ID: 3905278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.